X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Cadila Healthcare with TEVA PHARMACEUTICAL INDUSTRIES LTD. - Israel - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs TEVA PHARMA (Israel) - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CADILA HEALTHCARE   TEVA PHARMA
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-18
TEVA PHARMA
Dec-13
CADILA HEALTHCARE/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs5582,874-   
Low Rs3622,497-   
Sales per share (Unadj.) Rs116.31,649.6-  
Earnings per share (Unadj.) Rs17.9103.0-  
Cash flow per share (Unadj.) Rs23.1236.4-  
Dividends per share (Unadj.) Rs3.5090.21-  
Dividend yield (eoy) %0.83.4 22.7%  
Book value per share (Unadj.) Rs85.41,832.3-  
Shares outstanding (eoy) m1,023.74848.00-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.01.6 242.8%   
Avg P/E ratio x25.726.1 98.7%  
P/CF ratio (eoy) x19.911.4 174.9%  
Price / Book Value ratio x5.41.5 367.2%  
Dividend payout %19.687.5 22.4%   
Avg Mkt Cap Rs m470,6642,277,338 20.7%   
No. of employees `00011.844.9 26.3%   
Total wages/salary Rs m18,5450-   
Avg. sales/employee Rs Th10,072.731,123.0 32.4%   
Avg. wages/employee Rs Th1,569.10-   
Avg. net profit/employee Rs Th1,547.71,944.2 79.6%   
INCOME DATA
Net Sales Rs m119,0491,398,822 8.5%  
Other income Rs m1,1320-   
Total revenues Rs m120,1811,398,822 8.6%   
Gross profit Rs m28,475383,068 7.4%  
Depreciation Rs m5,388113,068 4.8%   
Interest Rs m91127,475 3.3%   
Profit before tax Rs m23,308242,525 9.6%   
Minority Interest Rs m6281,102 57.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-159,204 0.0%   
Tax Rs m5,644-2,961 -190.6%   
Profit after tax Rs m18,29287,383 20.9%  
Gross profit margin %23.927.4 87.3%  
Effective tax rate %24.2-1.2 -1,983.4%   
Net profit margin %15.46.2 246.0%  
BALANCE SHEET DATA
Current assets Rs m82,005944,759 8.7%   
Current liabilities Rs m60,720823,910 7.4%   
Net working cap to sales %17.98.6 207.0%  
Current ratio x1.41.1 117.8%  
Inventory Days Days7391 80.5%  
Debtors Days Days9896 102.5%  
Net fixed assets Rs m83,703456,886 18.3%   
Share capital Rs m1,0243,443 29.7%   
"Free" reserves Rs m86,4210-   
Net worth Rs m87,4451,553,826 5.6%   
Long term debt Rs m25,551715,249 3.6%   
Total assets Rs m180,6533,196,757 5.7%  
Interest coverage x26.69.8 270.5%   
Debt to equity ratio x0.30.5 63.5%  
Sales to assets ratio x0.70.4 150.6%   
Return on assets %10.63.6 295.8%  
Return on equity %20.95.6 372.0%  
Return on capital %22.04.9 445.9%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m31,4410-   
CASH FLOW
From Operations Rs m9,193222,900 4.1%  
From Investments Rs m-9,737-78,982 12.3%  
From Financial Activity Rs m515-267,383 -0.2%  
Net Cashflow Rs m-29-123,466 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 68.86 Rs / USD

Compare CADILA HEALTHCARE With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  

Compare CADILA HEALTHCARE With: DIVIS LABORATORIES  VENUS REMEDIES  DR. REDDYS LAB  DR. DATSONS LABS  DISHMAN PHARMA  



Today's Market

Sensex Opens Higher; Capital Goods and Power Stocks Lead(09:30 am)

Asian stock markets are lower today as Chinese and Hong Kong shares fall. The Shanghai Composite is off 1.2% while the Hang Seng is down 0.4%.

Related Views On News

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of CADILA HEALTHCARE for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of CADILA HEALTHCARE. Also includes updates on the valuation of CADILA HEALTHCARE.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

My Top 3 Defence Stocks to Buy Now(The 5 Minute Wrapup)

Mar 19, 2019

The urgency to privatise India's defence sector to make India self-reliant was never as strong as it is today.

Sensex Nearing All-Time Highs: Stocks to Buy in this Rally(Profit Hunter)

Mar 14, 2019

The BSE Sensex is heating up. In just a few days, the benchmark index is up 3%. Is this rally sustainable? Richa finds out...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Mar 22, 2019 10:17 AM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS